Sinusoidal Obstruction Syndrome (SOS) Withdrawn Phase 4 Trials for Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DB14105)

Also known as: Sinusoidal Obstruction Syndrome / Hepatic Veno-Occlusive Disease / Veno-occlusive disease of the liver (disorder) / Venoocclusive syndrome of the liver / Venoocclusive liver disease

DBCOND0136067 (Sinusoidal Obstruction Syndrome (SOS))Withdrawn4 IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic